ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan greenlights clinical tests on donor iPS cell transplants

Alternative treatment seen slashing cost, time

Researchers are optimistic that iPS cells will play a major role in regenerative medicine.

TOKYO -- The Japanese health ministry on Wednesday approved clinical research on a regenerative treatment that utilizes donated stem cells.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more